Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyou investments, today announced it has acquired a majority stake in Bedfont® Scientific Ltd. (“Bedfont”), which designs and manufactures non-invasive breath analysis medical devices.